Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Correvio Pharma Corp (CORV)

Correvio Pharma Corp (CORV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Correvio Pharma Corp 1441 Creekside Drive 6th Floor Vancouver A1 V6J 4S7 CAN

www.correvio.com P: 604-677-6905

Description:

Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 27,794
Shares Outstanding, K 66,191
Annual Sales, $ 32,630 K
Annual Net Income, $ -35,180 K
Last Quarter Sales, $ 11,330 K
Last Quarter Net Income, $ -4,940 K
60-Month Beta 0.08
% of Institutional Shareholders 7.30%
Float, K 66,191
% Float 100.00%

Growth:

1-Year Return -81.74%
3-Year Return -89.86%
5-Year Return -95.65%
5-Year Revenue Growth 8.62%
5-Year Earnings Growth 29.46%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 06/03/20
Earnings Per Share ttm -0.82
EPS Growth vs. Prev Qtr 56.52%
EPS Growth vs. Prev Year 44.44%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 04/12/13

CORV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,128.82%
Return-on-Assets % -58.56%
Profit Margin % -107.81%
Debt/Equity -34.42
Price/Sales 0.84
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.01
Interest Coverage -3.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar